CJC-1295 / Ipamorelin is a research-grade blend of two synthetic peptides supplied strictly for laboratory research use. This page describes what the compounds are and how each lot is characterized — reference information about identity, classification, and analytical testing, with no claim about any effect or application.
Identity and classification
CJC-1295 (no DAC) — also referred to as modified GRF(1-29) — is a synthetic peptide analog of growth-hormone-releasing hormone (GHRH). Ipamorelin is a synthetic pentapeptide classified as a selective growth-hormone secretagogue that acts as a ghrelin-receptor (GHS-R) agonist. Both are studied in laboratory research in the context of growth-hormone-axis signaling.
How each lot is tested
Every batch is analyzed by an independent, ISO/IEC 17025-accredited U.S. laboratory. Identity is confirmed by mass spectrometry against the expected molecular weight of each peptide, and purity is measured by HPLC-UV and reported per lot. See our Lab Testing & Analytical Methodology page for the full method.
Format and handling
Supplied as a lyophilized powder in a sealed vial and intended to be handled only by qualified professionals in an appropriate laboratory setting.
Documentation
Each lot ships with its own certificate of analysis. Review the certificates on our Lab Reports page, learn how to read a COA, and confirm a specific vial by its lot number on the Verify a Lot page. View this compound in the catalogue: CJC-1295 (no DAC) / Ipamorelin 15 mg.
For research use only
For research use only. Not for human or veterinary use; not for diagnostic or therapeutic use. This page is reference material and makes no claim regarding any effect, application, or outcome.